Paul Horstmeier - 07 Dec 2021 Form 4/A - Amendment Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Operating Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Issuer symbol
HCAT
Transactions as of
07 Dec 2021
Net transactions value
-$99,459
Form type
4/A - Amendment
Filing time
29 Dec 2021, 16:19:37 UTC
Date Of Original Report
09 Dec 2021
Previous filing
29 Dec 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Sale $83,215 -2,082 -2.1% $39.97 97,098 07 Dec 2021 Direct F1, F2
transaction HCAT Common Stock Sale $16,244 -400 -0.41% $40.61 96,698 07 Dec 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.
F2 Represents the weighted average sale price of the shares sold ranging from $39.46 to $40.42 per share, inclusive.
F3 Represents the weighted average sale price of the shares sold ranging from $40.58 to $40.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).